Gabapentin and solifenacin for overactive bladder in women
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether combining two medications (gabapentin and solifenacin) works better for women with overactive bladder who have urgency and leakage. It may offer a new option if standard treatments haven't helped enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with overactive bladder (OAB).
- You have at least a moderate symptom score, with strong urgency and leakage.
- You do NOT have a current urinary tract infection.
- You do NOT have nerve-related bladder problems (like from spinal cord injury or MS).
- Your main problem is not stress incontinence (leakage with coughing or sneezing).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a relaxation-based pelvic floor training program for women with overactive bladder and constipation. It may help improve bladder control and bowel function.
This trial compares electroacupuncture (a type of acupuncture using mild electrical stimulation) with solifenacin, a bladder medication, for women with overactive bladder. It aims to see which treatment works better to reduce bladder urgency and frequent urination.
This study tests whether adding electroacupuncture (a type of acupuncture with mild electrical pulses) to usual care can help control overactive bladder symptoms in women. If you are a woman aged 20–80 with overactive bladder and haven't tried certain treatments before, you may be eligible.
This trial tests a new procedure that uses radiofrequency energy to calm the nerve responsible for overactive bladder in women. It aims to reduce urge-related urine leaks without surgery or medications.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
Hear when a new Overactive Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.